Development and validation of an interpretable machine learning model for predicting urinary incontinence at 6 months after robot-assisted radical prostatectomy

开发和验证一种可解释的机器学习模型,用于预测机器人辅助根治性前列腺切除术后6个月的尿失禁情况

阅读:1

Abstract

Urinary incontinence adversely affects quality of life as a common complication after robot-assisted radical prostatectomy (RARP). To address this, our study sought to build and explain a machine learning (ML) model for predicting 6-month post-RARP incontinence risk. This single-center retrospective analysis enrolled 852 patients with localized prostate cancer (PCa) who underwent RARP from January 2021 to December 2024. Models were developed employing seven ML algorithms. Their performance was primarily evaluated through Receiver Operating Characteristic (ROC) curves and Decision Curve Analysis (DCA). Subsequently, the optimal model was interpreted using SHAP (SHapley Additive exPlanations) analysis. The final model incorporated seven key predictors: prostate volume, membranous urethral length (MUL), age, body mass index (BMI), transurethral resection of the prostate (TURP), T stage, and basal surgical margin status. In the testing set, the Light Gradient Boosting Machine (LightGBM) model demonstrated the best performance, achieving an AUC of 0.784 and an accuracy of 0.793. Through SHAP analysis, intuitive visualizations were generated to illustrate how each feature contributed to individual risk predictions. This ML-based prediction model accurately estimates the risk of urinary incontinence at 6 months after RARP and demonstrates favorable clinical utility. This tool provides a dependable means for timely detection and risk classification of patients at elevated risk, potentially enabling the adoption of tailored preventive measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11701-026-03386-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。